Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder

NCT01466205 is registered in ClinicalTrials.gov with Larry J. Siever as lead sponsor.

NCT NCT01466205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01466205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder
Lead sponsor
Larry J. Siever
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2011
Completion date
January 31, 2013
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairments, schizotypal personality disorder